SCHEMBL8575371

SCHEMBL8575371

COc1cc(OC)c2c(c1)OCC(c1ccccc1)(c1cccc(Cl)c1)C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 2/20 0.42
KDM4E B2RXH2 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP3A4 P08684 3/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
HSD17B10 Q99714 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
MAOB P27338 1/20 0.38
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ATM Q13315 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
ABHD10 Q9NUJ1 1/20 0.35
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8577569 0.88 ABCG2 (0.42) HTR6KDM4EALDH1A1CYP3A4ABCG2
SCHEMBL8577398 0.84 GAA (0.38) KDM4EHSD17B10ABCG2MAOBBACE1
SCHEMBL8574170 0.82 GAA (0.39) KDM4EALDH1A1ABCG2BACE1MEN1
SCHEMBL8575417 0.77 RIPK1 (0.41) HTR6KDM4EALDH1A1CYP3A4ABCG2
SCHEMBL31261716 0.77 ALDH1A1 (0.46) HTR6KDM4EALDH1A1CYP3A4HPGD
SCHEMBL8577523 0.76 ABCG2 (0.42) HTR6KDM4EALDH1A1CYP3A4HPGD
SCHEMBL8572826 0.76 CYP19A1 (0.37) ALDH1A1CYP3A4HSD17B10MAOBMEN1
SCHEMBL8572760 0.76 PLK1 (0.37) ALDH1A1CTSDBACE1
SCHEMBL8577389 0.72 GLRA3 (0.34) CYP3A4HPGDMAPK1MEN1KMT2A
SCHEMBL8576216 0.72 GAA (0.38) KDM4EALDH1A1ABCG2BACE1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998017662-A1 PHENYL-SUBSTITUTED BICYCLIC HETEROCYCLYL DERIVATIVES AND THEIR USE NOVARTIS AG (CH) 1998-04-30 WO disclosed